Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin–DNA adduct formation in patients and ovarian cancer cell lines
- 1 January 1998
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (1) , 148-154
- https://doi.org/10.1016/s0959-8049(97)00370-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effect of Hyperthermia on the Number of Platinum Atoms Binding to DNA of HeLa Cells Treated with195mPt-radiolabelledcis-diaminedichloroplatinum(II)International Journal of Radiation Biology, 1994
- Local treatment of rabbit VX2 rectal carcinoma with combined hyperthermia and intratumoral CDDP injectionInternational Journal of Hyperthermia, 1994
- Long-term survival in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in ratsEuropean Journal of Cancer and Clinical Oncology, 1991
- Characterization of the DNA damage recognized by the antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNACarcinogenesis: Integrative Cancer Research, 1990
- A review: Intraperitoneal cisplatin in the management of patients with ovarian cancerGynecologic Oncology, 1990
- Experimental and clinical status of intraperitoneal chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1990
- Ultrastructural changes induced by hyperthermia in Chinese hamster V79 fibroblastsInternational Journal of Hyperthermia, 1989
- A Critical Appraisal of the Human Tumor Stem-Cell AssayNew England Journal of Medicine, 1983
- The Natural History and Treatment of Ovarian CancerAnnual Review of Medicine, 1981